ForecastedResearch announcementOpportunity FOR-FD-23-006

FDA OMHHE Convener for Racial & Ethnic minority Acceleration Consortium for Health Equity (REACH)

Food and Drug Administration · Department of Health and Human Services

At a glance

FDA OMHHE Convener for Racial & Ethnic minority Acceleration Consortium for Health Equity (REACH) is a forecasted federal cooperative agreement opportunity from the Food and Drug Administration (Department of Health and Human Services). The agency's forecast estimates an application due date of March 3, 2023; forecast dates can change. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 9 more. Cost sharing is not required. It is funded under Assistance Listing 93.103 (Food and Drug Administration Research).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Jul 6, 2022Forecast posted
Jan 3, 2023 (est.)Full notice expected
Mar 3, 2023 (est.)Application deadline

Posted: Jul 6, 2022
Est. close date: Mar 3, 2023
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: Not specified
Expected awards: 1
Cost sharing: Not required
Funding instrument: Cooperative Agreement
Opportunity category: Discretionary
Fiscal year: FY2023

Typical awards for this program (SAM.gov listing for ALN 93.103, not this notice): Varies by grant mechanism and program specific requirements.

Who can apply

State governments
County governments
City or township governments
Special district governments
Independent school districts
Public colleges & universities
Federally recognized tribal governments
Public & Indian housing authorities
Native American tribal organizations
501(c)(3) nonprofits
Nonprofits without 501(c)(3) status
Private colleges & universities
For-profit organizations (not small businesses)
Small businesses

Can your organization apply?

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

The goal of this FOA is to support a convener for FDA OMHHE's Racial & Ethnic minority Acceleration Consortium for Health Equity (REACH). REACH, supported through a separate FOA, will consist of 5-8 multi-project cooperative agreement (U01) awardees that will strengthen and advance minority health and health equity regulatory needs by supporting communications, research, and collaboration on diseases and conditions that disproportionately impact racial and ethnic minority populations, as well as prepare for and proactively respond to existing/emerging threats that impact racial and ethnic minority and other underrepresented or undeserved communities.

The REACH convener supported by this FOA will be responsible for: coordinating cross-REACH data integration, analysis, and visualization; coordinating convening, workshops, and fostering collaborations amongst REACH investigators by managing the REACH subcommittees and an infrastructure to support collaborative studies.

How to apply

0 of 8 done · progress saved in this browser

Read the full announcement (NOFO)Eligibility, evaluation criteria, page limits and required attachments are in the full notice on Grants.gov. Open ↗
Confirm eligibility and fitCheck your organization type above; no cost sharing is required.
Register (or renew) in SAM.gov and get a UEIFree. New registrations can take several weeks; registrations must be renewed every year. Open ↗
Set up Grants.gov accessCreate a Grants.gov account and make sure someone has the Authorized Organization Representative (AOR) role. Open ↗
Watch for the full noticeThe agency estimates posting it around January 3, 2023. Save this grant to track changes.
Prepare narrative, budget and attachmentsFollow the notice's format exactly — page limits and required forms are common reasons applications are rejected.
Ask the agency contact any questions earlyShashi Malhotra Grants Management Specialist · shashi.malhotra@fda.hhs.gov Open ↗
Submit before March 3, 2023Submit a few days early and keep your Grants.gov confirmation and validation emails.

Assistance Listing

What is an ALN?

93.103Food and Drug Administration ResearchProgram →

Reported obligations under ALN 93.103

Historical data · not a prediction

FY18

$173M

FY19

$199M

FY20

$212M

FY21

$219M

FY22

$256M est.

FY23

$247M est.

Source: SAM.gov Assistance Listing 93.103. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Shashi Malhotra Grants Management Specialist
shashi.malhotra@fda.hhs.gov
2404027592

Quick answers

Is this opportunity open for applications yet?

Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around January 3, 2023. Forecast details and dates can change.

Who is eligible to apply for this opportunity?

The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 2 more. Additional restrictions may apply; review the full notice.

How do I apply for this opportunity?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity FOR-FD-23-006), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

ForecastedResearchALN 93.103